Day: June 13, 2023

Mushroom Holding Company Announces New Line of Functional Mushroom Product Backed by Basketball Hall of Famer PORTLAND, OR, June 13, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – GrowLife, Inc. (OTCQB: PHOT) today announced that its wholly-owned subsidiary Bridgetown Mushrooms (the “Company,”), a leading organic producer and supplier of fresh gourmet mushrooms, functional mushroom products, and mycology supplies, has released a limited edition functional mushroom bar—Bill Walton’s Wonder Bar. The Company and Bill Walton, Basketball Hall of Famer, announced their brand partnership in March 2023.  The limited edition dark chocolate bar infused with lion’s mane mushrooms marks the Company’s formal entrance into the burgeoning mushroom-fueled consumable market, projected to be valued at $27.6 billion in 2021 by Grandview Research. Bill...

New luxury townhome community offers urban living features in a convenient suburban locationOverlook at Town Center by Toll Brothers Toll Brothers announces two newly opened model homes at Overlook at Town Center in King of Prussia, Pennsylvania.KING OF PRUSSIA, Pa., June 13, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of its new model homes at Overlook at Town Center, the only new-construction townhome community at The Village at Valley Forge in King of Prussia, Pennsylvania, offering city-like living in a convenient suburban location. Townhome prices start in the mid-$500,000s. The highly anticipated Overlook at Town Center model homes showcase the innovative architectural designs for the second phase of the community, complemented...

Press Release Eviden launches “AIsaac Cyber Mesh”, strengthened by AWS, for reinforced cyber resilience “re:Inforce”, Anaheim, California and Paris, France – June 13, 2023 – Eviden, an Atos business, a leader in digital, cloud, big data and security, today announces AIsaac Cyber Mesh, a next generation of cybersecurity detection and response, reinforced by Amazon Web Services (AWS) Security Data Lake and powered by generative AI technologies. AIsaac Cyber Mesh offers an advanced end-to-end detection, response, and recovery solution, built on a cybersecurity mesh-enabled architecture1using generative AI and predictive analytics. Combined with Amazon Security Lake, which centralizes data from multiple sources including on-premises and custom sources, AIsaac Cyber Mesh enables businesses to have a more complete understanding of the scope...

WALL, N.J., June 13, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), announced today that following the filing of its Form 10-Q for the quarter ended March 31, 2023, The Nasdaq Stock Market, LLC has informed the Company that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company’s Form 10-Q filing was delayed because the compilation and review of certain financial information could not be completed within the prescribed time period without unreasonable effort and expense. About BIO-key International, Inc. (www.BIO-key.com)BIO-key is...

Approval heralds the second rare cholestatic liver disease indication for Bylvay in the U.S. after progressive familial intrahepatic cholestasis related pruritus in 2021 Immediate U.S. commercial launch and availability for eligible patients ASSERT clinical study demonstrated efficacy of Bylvay in improvement of pruritus. Also showed improvement in certain sleep disturbances and reduction in bile acids – which were secondary endpoints – with a low drug-related diarrhea rate in patients with Alagille syndrome Committee for Medicinal Products for Human Use opinion expected in Q2 2023 with final European Medicines Agency decision in second half of 2023PARIS, FRANCE, 13 June 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has approved Bylvay® (odevixibat) for the treatment of cholestatic...

BOCA RATON, Fla., June 13, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced it has entered into agreements with certain holders of its existing warrants exercisable for 1,681,667 shares of its common stock, in the aggregate, to exercise their warrants at a reduced exercise price of $1.15 per share, in exchange for new warrants as described below. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $2.4 million, before deducting financial advisory fees. The reduction in the exercise price of the existing warrants and the issuance of the new warrants...

Totalbankens repræsentantskab bakker op om fusionen af Totalbanken og Sparekassen Danmark Totalbankens repræsentantskab har på et ekstraordinært repræsentantskabsmøde dags dato behandlet bestyrelsens forslag om en fusion af Totalbanken A/S (”Totalbanken”) og Sparekassen Danmark (”Sparekassen”) med Sparekassen som det fortsættende pengeinstitut. For nærmere oplysninger om den foreslåede fusion henvises til selskabsmeddelelse nr. 8/2023.Attachment2023-10 Totalbankens repræsentantskab bakker op om fusionen 20230613

Aspo PlcInside informationJune 13, 2023, at 7.45 p.m. Correction: This stock exchange release includes the same inside information that was incorrectly made public through a press release on June 12, 2023, at 10:15 p.m. Correction, inside information: Aspo’s subsidiary Leipurin signs a sale and lease back agreement for its property in Tyresö, Sweden Aspo’s subsidiary Leipurin has signed a sale and lease back agreement for its property in Tyresö, Sweden. The property came into Leipurin’s ownership via the Kobia acquisition that took place on 1 September 2022. The buyer of the property is Revelop, a Swedish real estate investor. With this transaction, Leipurin completes the program to sell and lease back the three properties it obtained in the Kobia acquisition. The aggregated sales price of the Gothenburg, Hässleholm and Tyresö properties...